These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29630744)

  • 1. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
    Ghodousi ES; Rahgozar S
    J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia.
    Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N
    Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
    Pouyanrad S; Rahgozar S; Ghodousi ES
    Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
    Ghodousi ES; Aberuyi N; Rahgozar S
    Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.
    Rahgozar S; Moafi A; Abedi M; Entezar-E-Ghaem M; Moshtaghian J; Ghaedi K; Esmaeili A; Montazeri F
    Cancer Biol Ther; 2014 Jan; 15(1):35-41. PubMed ID: 24145140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
    Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
    Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
    Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.
    Rzepiel A; Kutszegi N; Gézsi A; Sági JC; Egyed B; Péter G; Butz H; Nyírő G; Müller J; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
    J Transl Med; 2019 Nov; 17(1):372. PubMed ID: 31727091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia.
    Efferth T; Gillet JP; Sauerbrey A; Zintl F; Bertholet V; de Longueville F; Remacle J; Steinbach D
    Mol Cancer Ther; 2006 Aug; 5(8):1986-94. PubMed ID: 16928819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia.
    Aberuyi N; Rahgozar S; Khosravi Dehaghi Z; Moafi A; Masotti A; Paolini A
    Onco Targets Ther; 2017; 10():3373-3380. PubMed ID: 28744141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of microRNA-181a and microRNA-196b in Egyptian Pediatric acute Lymphoblastic Leukemia.
    Shafik RE; Abd El Wahab N; Mokhtar MM; El Taweel MA; Ebeid E
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3429-3434. PubMed ID: 33247705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
    Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
    Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia.
    Steinbach D; Gillet JP; Sauerbrey A; Gruhn B; Dawczynski K; Bertholet V; de Longueville F; Zintl F; Remacle J; Efferth T
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4357-63. PubMed ID: 16857811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A semantics-oriented computational approach to investigate microRNA regulation on glucocorticoid resistance in pediatric acute lymphoblastic leukemia.
    Chen H; Zhang D; Zhang G; Li X; Liang Y; Kasukurthi MV; Li S; Borchert GM; Huang J
    BMC Med Inform Decis Mak; 2018 Jul; 18(Suppl 2):57. PubMed ID: 30066657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
    Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
    Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer.
    Chen J; Tian W; Cai H; He H; Deng Y
    Med Oncol; 2012 Dec; 29(4):2527-34. PubMed ID: 22101791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.
    Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA
    Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.